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Abstract 14 
Studies combined in a meta-analysis often have differences in their design and conduct that 15 
can lead to heterogeneous results. A random-effects model accounts for these differences in 16 
the underlying study effects, which includes a heterogeneity variance parameter. The 17 
DerSimonian-Laird method is often used to estimate the heterogeneity variance, but simulation 18 
studies have found the method can be biased and other methods are available. This paper 19 
compares the properties of nine different heterogeneity variance estimators using simulated 20 
meta-analysis data. Simulated scenarios include studies of equal size and of moderate and large 21 
differences in size. Results confirm that the DerSimonian-Laird estimator is negatively biased 22 
in scenarios with small studies, and in scenarios with a rare binary outcome. Results also show 23 
the Paule-Mandel method has considerable positive bias in meta-analyses with large 24 
2 
 
differences in study size. We recommend the method of restricted maximum likelihood 25 
(REML) to estimate the heterogeneity variance over other methods. However, considering that 26 
meta-analyses of health studies typically contain few studies, the heterogeneity variance 27 
estimate should not be used as a reliable gauge for the extent of heterogeneity in a meta-28 
analysis. The estimated summary effect of the meta-analysis and its confidence interval derived 29 
from the Hartung-Knapp-Sidik-Jonkman method is more robust to changes in the heterogeneity 30 
variance estimate and shows minimal deviation from the nominal coverage of 95% under most 31 
of our simulated scenarios. 32 
Keywords 33 
Heterogeneity, simulation, random-effects, DerSimonian-Laird, REML 34 
1 Introduction 35 
Meta-analysis is the statistical technique of combining the results of multiple comparable 36 
studies. These studies often have differences in their design and conduct that lead to 37 
heterogeneity in their underlying effects. When heterogeneity is thought to be present, 38 
researchers should first attempt to find its causes, but these causes may be too numerous to 39 
isolate or may simply be unknown. Unexplained heterogeneity of study effects can be 40 
quantified in a random-effects model. This model typically assumes a normal distribution of 41 
the underlying effects across studies. A reliable estimate of the variance of this distribution can 42 
provide valuable insight into the degree of heterogeneity between studies, even if such studies 43 
are not formally synthesised in a meta-analysis. 44 
The moment-based method proposed by DerSimonian-Laird method (DerSimonian and Laird, 45 
1986) is most commonly used to estimate the heterogeneity variance. However, this method 46 
has been shown in previous simulation studies to be negatively biased in meta-analyses 47 
containing small studies (Malzahn et al., 2000), particularly in meta-analyses of binary 48 
outcomes (Novianti et al., 2014; Sidik and Jonkman, 2007). There are many other available 49 
methods (Veroniki et al., 2015), including those proposed by Paule and Mandel (1982), 50 
Hartung and Makambi (2003), Sidik and Jonkman (2005, 2007), and the restricted maximum 51 
likelihood method (REML) (Harville, 1977). Estimates derived from these methods in the same 52 
meta-analysis can often be notably different and in a small number of cases, these estimates 53 
can produce discordant conclusions on the summary effect and its confidence interval (Langan 54 
et al., 2015). Therefore, the choice of heterogeneity variance method is an important 55 
consideration in a meta-analysis. Research based on simulated meta-analysis data can allow a 56 
researcher to make a more informed decision. 57 
A recent systematic review collated simulation studies that compare the properties of 58 
heterogeneity variance estimators (Langan et al., 2016). Its aim was to assess if there is 59 
consensus on which heterogeneity variance methods (if any) have better properties than 60 
DerSimonian-Laird. The review identified 12 relevant simulation studies, but there was little 61 
consensus across the various authors’ recommendations (Malzahn et al., 2000; Novianti et al., 62 
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2014; Sidik and Jonkman, 2005; Sidik and Jonkman, 2007; Panityakul et al., 2013; 63 
Viechtbauer, 2005; Rukhin et al., 2000; Bhaumik et al., 2012; Knapp and Hartung, 2003; 64 
Sanchez-Meca and Marin-Martinez, 2008; Kontopantelis et al., 2013; Chung et al., 2013). This 65 
may have been caused by a potential conflict of interest among the authors of all but four of 66 
these studies (Novianti et al., 2014; Panityakul et al., 2013; Viechtbauer, 2005; Sanchez-Meca 67 
and Marin-Martinez, 2008); the authors of these eight studies recommended their own newly 68 
proposed methods over existing methods. Three of the simulation studies (Novianti et al., 2014; 69 
Panityakul et al., 2013; Viechtbauer, 2005) compared only pre-existing methods and made an 70 
explicit recommendation for estimating the heterogeneity variance; the authors of these studies 71 
recommended the method of Paule and Mandel (1982) and/or REML (Harville, 1977), but only 72 
compared a subset of methods. 73 
The tentative conclusions of that review provided motivation for a new simulation study, which 74 
we present in this paper. The limitations of previous simulation studies helped inform the 75 
design of this study. We consider the inclusion of all methods identified in recent reviews of 76 
heterogeneity variance methods (Veroniki et al., 2015; Langan et al., 2016), compare methods 77 
comprehensively in a range of simulated scenarios representative of meta-analyses of health 78 
studies, and report a wide range of performance measures. Performance measures include those 79 
that relate directly to the heterogeneity variance estimates, and those that measure the impact 80 
of heterogeneity variance estimates on the summary effect estimate and its confidence interval. 81 
Our recommendations are based on a subjective trade-off between many performance 82 
measures. To minimise any conflict of interest, we do not propose any new methods in this 83 
paper. 84 
The aims of this simulation study are to: (1) compare the relative performance of heterogeneity 85 
variance methods to establish which method(s) have the most reasonable properties; (2) find 86 
scenarios where the performance of all methods is poor, such that we cannot rely on a single 87 
method to provide an estimate. In scenarios where all methods perform poorly, we make wider 88 
recommendations for random-effects meta-analysis and dealing with between-study 89 
heterogeneity. 90 
The outline of the paper is as follows. In section 2, we introduce methods for estimating the 91 
heterogeneity variance and any other meta-analysis methods relevant to this simulation study. 92 
The design of the simulation study is given in section 3, followed by the results of this study 93 
in section 4. Results are discussed and conclusions are drawn in sections 5 and 6. 94 
2 Methods 95 
2.1 The heterogeneity variance parameter in a random-effects model 96 
A random-effects model accounts for the possibility that underlying effects differ between 97 
studies in a meta-analysis. The random-effects model is defined as: 98 
𝜃𝑖 = 𝜃𝑖 + 𝜀𝑖 99 
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                        𝜃𝑖 = 𝜃 + 𝛿𝑖 ,                                                                    (1) 100 
where 𝜃𝑖 is the true effect size in study i, 𝜃𝑖 is the estimated effect size, and 𝜃 is the average 101 
effect across all studies. 𝜀𝑖 and 𝛿𝑖 are the within-study errors and the between-study 102 
heterogeneity respectively. Meta-analysis methods typically assume that both are normally 103 
distributed, i.e. 𝜀𝑖~𝑁(0, 𝜎𝑖
2) and 𝛿𝑖~𝑁(0, 𝜏
2). The heterogeneity variance parameter is a 104 
measure of the variance of 𝜃𝑖 around 𝜃 and is denoted by 𝜏
2.  105 
The inverse-variance method is most commonly used to estimate 𝜃 in this model; the estimate 106 
is given by: 107 
𝜃 =∑𝑤𝑖 𝜃𝑖
𝑘
𝑖=1
∑𝑤𝑖
𝑘
𝑖=1
,⁄                                                             (2) 108 
where 𝑘 is the number of studies in the meta-analysis and 𝑤𝑖 is the weight given to study i. 109 
Under the random-effects model, using weights 𝑤𝑖 = 1 (𝜎𝑖
2 + 𝜏2)⁄  provides the uniformly 110 
minimum variance unbiased estimator (UMVUE) of 𝜃, which we denote by 𝜃𝑅𝐸. When 𝜏
2 =111 
0, model (1) simplifies to what is commonly referred to as the fixed-effect model, where the 112 
true effects are homogeneous. In that case, the UMVUE of 𝜃 (which is now the common true 113 
effect for all 𝑘 studies) is obtained with (2), but using weights 𝑤𝑖 = 1 𝜎𝑖
2⁄ . We denote this 114 
estimator by 𝜃𝐹𝐸 . However, the variance parameters 𝜎𝑖
2 and 𝜏2 are unknown in practice and 115 
must be estimated from the data. Methods to estimate 𝜏2 are outlined in the next section. 116 
2.2 Heterogeneity variance estimators 117 
Nine estimators were identified from two systematic reviews of heterogeneity variance 118 
methods (Veroniki et al., 2015; Langan et al., 2016). Estimators proposed by Hunter and 119 
Schmidt (2004), Rukhin (2000), Malzahn et al. (2000) and the maximum likelihood method 120 
proposed by Hardy and Thompson (1996) are present in these reviews but excluded from the 121 
main results because preliminary analysis showed they are clearly inferior to other methods (as 122 
shown in appendix 1). Furthermore, Bayesian methods that rely on a subjective choice of prior 123 
distribution are excluded because of difficulty in objectively comparing them to frequentist 124 
methods. The method proposed by Morris (1983) is excluded because it is an approximation to 125 
REML. We excluded the positive DerSimonian-Laird estimator (Kontopantelis et al., 2013), 126 
which truncates heterogeneity variance estimates below 0.01, because any positive cut-off 127 
value could be applied. 128 
The included heterogeneity variance estimators are listed in table 1. This table also includes 129 
acronyms for the estimators used throughout this paper. Their formulae are given below. 130 
Table 1: Nine heterogeneity variance estimators included in this simulation study 131 
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Method of moments approach (estimators 1-5) 132 
Five estimators included in this study can be derived from the method of moments approach, 133 
which is based on the generalised Q-statistic (DerSimonian and Kacker, 2007): 134 
𝑄𝑀𝑀 =∑𝑎𝑖(𝜃𝑖 − 𝜃)
2
𝑘
𝑖=1
 135 
The weight assigned to study i is denoted by 𝑎𝑖 and calculated differently depending on which 136 
of the five method of moments estimators is used. 𝜃 is given by formula (2) with study weights 137 
𝑤𝑖 = 𝑎𝑖. By equating 𝑄𝑀𝑀 to its expected value, the following general formula for the 138 
heterogeneity variance can be derived (see DerSimonian and Kacker (2007)) for a detailed 139 
derivation): 140 
?̂?2 = 𝑚𝑎𝑥
{
 
 
 
 
0,
𝑄𝑀𝑀 − ∑ 𝑎𝑖?̂?𝑖
2𝑘
𝑖=1 +
∑ 𝑎𝑖
2?̂?𝑖
2𝑘
𝑖=1
∑ 𝑎𝑖
𝑘
𝑖=1
∑ 𝑎𝑖
𝑘
𝑖=1 −
∑ 𝑎𝑖
2𝑘
𝑖=1
∑ 𝑎𝑖
𝑘
𝑖=1 }
 
 
 
 
                                             (3) 141 
1. The DerSimonian-Laird estimator (DL) (DerSimonian and Laird, 1986) uses the fixed-effect 142 
model weights 𝑎𝑖 = 1 ?̂?𝑖
2⁄ , which leads to the formula: 143 
?̂?𝐷𝐿
2 = 𝑚𝑎𝑥
{
 
 
 
 
0,
∑ (1 ?̂?𝑖
2⁄ )(𝜃𝑖 − 𝜃𝐹𝐸)
2𝑘
𝑖=1 − (𝑘 − 1)
∑ (1 ?̂?𝑖
2⁄ )𝑘𝑖=1 −
∑ (1 ?̂?𝑖
2⁄ )2𝑘𝑖=1
∑ (1 ?̂?𝑖
2⁄ )𝑘𝑖=1 }
 
 
 
 
 144 
2. Cochran’s ANOVA estimator (CA) uses equal study weights 𝑎𝑖 = 1 𝑘⁄ , leading to: 145 
?̂?𝐶𝐴
2 = 𝑚𝑎𝑥 {0,
1
𝑘−1
∑ (𝜃𝑖 − 𝜃𝐶𝐴)
2𝑘
𝑖=1 −
1
𝑘
∑ ?̂?𝑖
2𝑘
𝑖=1 } , where 𝜃𝐶𝐴 is calculated from formula (2) 146 
with study weights 𝑤𝑖 = 1 𝑘⁄ . 147 
3. The Paule-Mandel estimator (PM) uses the random-effects model study weights, defined by 148 
substituting 𝑎𝑖 = 1 (?̂?𝑖
2 + ?̂?𝑃𝑀
2 )⁄  into formula (3). Since 𝑎𝑖 is a function of ?̂?𝑃𝑀
2 , there is no 149 
closed-form expression for ?̂?𝑃𝑀
2  and iteration is required to find the solution. Iterative 150 
algorithms including those suggested by Bowden et al. (2011) and Jackson et al. (2014) always 151 
converge. The same estimator has been derived independently of the methods of moments 152 
approach and is therefore often referred to as the empirical Bayes estimator in the literature 153 
(Rukhin, 2013). 154 
4. The two-step Cochran’s ANOVA estimator also uses Paule-Mandel random-effects weights 155 
but restricts iteration to two-steps (PMCA). Cochran’s ANOVA is used to initially estimate 𝜏2, 156 
thus, a closed form expression can be derived by substituting 𝑎𝑖 = 1 (?̂?𝑖
2 + ?̂?𝐶𝐴
2 )⁄  into formula 157 
(3). 158 
5. The two-step DerSimonian-Laird estimator (PMDL) has similar weights as PMCA above, but 159 
uses the DerSimonian-Laird method to calculate an initial estimate of 𝜏2. Therefore the study 160 
weights are 𝑎𝑖 = 1 (?̂?𝑖
2 + ?̂?𝐷𝐿
2 )⁄ . 161 
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All five of these methods can produce negative variance estimates and are truncated to zero in 162 
such cases. 163 
Hartung-Makambi (estimator 6) 164 
Hartung and Makambi (2003) proposed a correction to the DerSimonian-Laird estimator so 165 
that ?̂?2 is always positive and truncation is not required. The formula is given by: 166 
?̂?𝐻𝑀
2 =
(∑ (1 ?̂?𝑖
2⁄ )(𝜃𝑖 − 𝜃𝐹𝐸)
2𝑘
𝑖=1 )
2
(∑ (1 ?̂?𝑖
2⁄ )𝑘𝑖=1 −
∑ (1 ?̂?𝑖
2⁄ )2𝑘𝑖=1
∑ (1 ?̂?𝑖
2⁄ )𝑘𝑖=1
) (2(𝑘 − 1) + ∑ (1 ?̂?𝑖
2⁄ )(𝜃𝑖 − 𝜃𝐹𝐸)
2𝑘
𝑖=1 )
 167 
Sidik-Jonkman (estimators 7 and 8) 168 
Sidik and Jonkman (2005) proposed the following two-step estimator that only produces 169 
positive 𝜏2 estimates: 170 
?̂?𝑆𝐽
2 =
1
𝑘 − 1
∑
1
1 + (?̂?𝑖
2/?̂?0
2)
(𝜃𝑖 − 𝜃𝑆𝐽)
2
 ,
𝑘
𝑖=1
 171 
where ?̂?0
2 =
1
𝑘−1
∑ (𝜃𝑖 − 𝜃𝐶𝐴)
2𝑘
𝑖=1  is the initial heterogeneity variance estimate and 𝜃𝑆𝐽 is 172 
calculated from formula (2) with weights 𝑤𝑖 = 1 (1 + (?̂?𝑖
2/?̂?0
2))⁄ . 173 
Sidik and Jonkman (2005) noted that an alternative formula for ?̂?0
2 may lead to an estimator 174 
with better properties. In a subsequent paper (2007), they proposed an alternative initial 175 
estimate ?̂?0
2 = 𝑚𝑎𝑥{0.01, ?̂?𝐶𝐴
2 }, where ?̂?𝐶𝐴
2  is Cochran’s ANOVA estimate of the heterogeneity 176 
variance (estimator 2). 177 
Restricted maximum likelihood (estimator 9) 178 
To derive the restricted maximum likelihood (REML) estimator, the log-likelihood function 179 
from the random-effects model (1) derived from the maximum likelihood method (Hardy and 180 
Thompson, 2004) is transformed so that it excludes the parameter 𝜃 (Harville, 1977). In doing 181 
so, REML avoids making the assumption that 𝜃 is known and is therefore thought to be an 182 
improvement on the original maximum likelihood estimator (Viechtbauer, 2005). This results 183 
in the following modified log-likelihood function: 184 
 185 
𝑙 = −
𝑘
2
𝑙𝑛(2𝜋) −
1
2
∑ 𝑙𝑛(𝜎𝑖
2 + 𝜏2)
𝑘
𝑖=1
−
1
2
∑
(𝜃𝑖 − 𝜃)
𝜎𝑖
2 + 𝜏2
𝑘
𝑖=1
−
1
2
𝑙𝑛 (∑
1
𝜎𝑖
2 + 𝜏2
𝑘
𝑖=1
) 186 
 187 
Maximising this modified log-likelihood function with respect to 𝜏2 (by differentiating and 188 
setting equal to zero) results in the following formula for the heterogeneity variance: 189 
?̂?𝑅𝐸𝑀𝐿
2 = 𝑚𝑎𝑥 {0,
∑ 𝑎𝑖
2 ((𝜃𝑖 − 𝜃𝑅𝐸)
2
− ?̂?𝑖
2)𝑘𝑖=1
∑ 𝑎𝑖
2𝑘
𝑖=1
+
1
∑ 𝑎𝑖
𝑘
𝑖=1
}, 190 
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where 𝑎𝑖 = 1 (?̂?𝑖
2 + ?̂?𝑅𝐸𝑀𝐿
2 )⁄ . 191 
The heterogeneity variance estimate is calculated through a process of iteration. Fisher’s 192 
scoring algorithm is used for iteration in this study, as implemented in the metafor package in 193 
R (Viechtbauer, 2010). 194 
2.3 Confidence interval methods for the summary effect 195 
In this study, we also investigate how choice of a particular heterogeneity variance estimation 196 
method may impact on the estimate of the summary effect 𝜃 and its confidence interval. As we 197 
described earlier, the inverse-variance method is typically used to estimate 𝜃 in a random-198 
effects meta-analysis, so we calculate 𝜃 using this method throughout. The following are three 199 
methods to estimate a corresponding confidence interval. 200 
A Wald-type confidence interval can be calculated as (DerSimonian and Laird, 1986): 201 
𝜃 ± Z(1−𝐶) 2⁄ √𝑉𝑎𝑟(𝜃) 202 
𝑉𝑎𝑟(𝜃) = 1 (∑ 1 (?̂?𝑖
2 + ?̂?2)⁄
𝑘
𝑖=1
)⁄                                              (4) 203 
where C is the coverage level of the confidence interval, and 𝑍(1−𝐶) 2⁄  is the (1 − 𝐶) 2⁄  centile 204 
of the standard normal distribution (e.g. 𝑍(1−0.95) 2⁄ = 1.96) 205 
Alternatively, a t-distribution can be assumed for the summary effect with 𝑘 − 1 degrees of 206 
freedom (Follmann and Proschan, 1999): 207 
𝜃 ± 𝑡𝑘−1, (1−𝐶) 2⁄ √𝑉𝑎𝑟(𝜃) , 208 
where 𝑡𝑘−1, (1−𝐶) 2⁄  is the (1 − 𝐶) 2⁄  centile of the t-distribution with 𝑘 − 1 degrees of freedom 209 
and 𝑉𝑎𝑟(𝜃) is calculated from formula (4). 210 
The Hartung-Knapp-Sidik-Jonkman method (HKSJ) (Hartung and Knapp, 2001; Sidik and 211 
Jonkman, 2002) also relies on a t-distribution and uses an alternative weighted variance for 𝜃: 212 
𝜃 ± 𝑡𝑘−1, (1−𝐶) 2⁄ √𝑉𝑎𝑟𝐻𝐾𝑆𝐽(𝜃) 213 
𝑉𝑎𝑟𝐻𝐾𝑆𝐽(𝜃) =
∑ 𝑎𝑖
𝑘
𝑖=1 (𝜃𝑖 − 𝜃)
2
(𝑘 − 1)∑ 𝑎𝑖
𝑘
𝑖=1
, 214 
where 𝑎𝑖 = 1 (?̂?𝑖
2 + ?̂?2)⁄ ,  𝜃 is calculated from formula (2) and ?̂?2 can be estimated using any 215 
of the methods outlined in this paper. 216 
This method is equivalent to the t-distribution method above, but its variance is multiplied by 217 
a scaling factor ∑ 𝑎𝑖
𝑘
𝑖=1 (𝜃𝑖 − 𝜃)
2
(𝑘 − 1)⁄  (Sidik and Jonkman, 2002; Wiksten et al., 2016). 218 
In certain cases, this scaling factor can be less than one, which leads to a narrower confidence 219 
8 
 
interval than the standard t-distribution approach and can also lead to a narrower interval 220 
compared to the Wald-type method in few cases (Higgins and Thompson, 2002). A variation 221 
of this method has been proposed to deal with this by constraining the scaling factor to be ≥ 1 222 
(Hartung and Makambi, 2003). However, throughout this study, the HKSJ method without 223 
constraint is used. 224 
3 Simulation study design 225 
All simulations and analyses were carried out in R version 3.2.2. The package metafor 226 
(Viechtbauer, 2010) was used to run simulated meta-analyses and calculate heterogeneity 227 
variance estimates from methods coded in this package, bespoke code was used for those that 228 
are not. A study protocol was agreed by all authors before running these simulations and is 229 
available upon request from the first author. 230 
3.1 Simulation methods 231 
For studies 𝑖 = 1,… , 𝑘 in each meta-analysis, true study effects 𝜃𝑖 are simulated from the 232 
distribution 𝑁(𝜃, 𝜏2). Parameters 𝜃, 𝜏2, and 𝑘 take values as defined in section 3.2. Study 233 
sample sizes 𝑁𝑖 are generated from a distribution also detailed in section 3.2 and are then split 234 
evenly between the two study groups 𝑛1𝑖 and 𝑛2𝑖. Participant-level data are then simulated for 235 
both continuous and binary outcomes, and effect sizes and within-study variances (𝜃𝑖 and 𝜎𝑖
2) 236 
are estimated from these data. In continuous outcome meta-analyses, effects are measured as a 237 
standardised mean difference and in binary outcome meta-analyses, effects are measured as a 238 
log-odds ratio. 239 
For each study simulated from continuous outcome data, the following steps are carried out:  240 
(1) Generate 𝑛1𝑖 observations from 𝑁(0, 𝜎1𝑖
2 ) and 𝑛2𝑖 observations from 𝑁(𝜃𝑖 , 𝜎2𝑖
2 ). We 241 
assume variances 𝜎1𝑖
2  and 𝜎2𝑖
2  in the two groups are equal and, without loss of generality, 242 
set them equal to 1. 243 
(2) Calculate the sample means and standard deviations of these observations. 244 
(3) Calculate 𝜃𝑖 and ?̂?𝑖
2 for standardised mean differences by Hedges’ g method, thus 245 
accounting for small sample bias of standardised mean differences (Borenstein et al., 246 
1999, equations 2.23 and 2.24). 247 
For studies with an odds ratio outcome measure: 248 
(1) Generate an average event probability between the two study groups (?̅?𝑖) from one of 249 
the distributions as defined in section 3.2. Although this simulation approach is not 250 
common, Smith et al. (1995) has previously defined a Bayesian meta-analysis model 251 
that included the same ?̅?𝑖 parameter. 252 
(2) Derive underlying event probabilities for each study group (𝑝1𝑖 and 𝑝2𝑖) from the 253 
solutions to the following simultaneous equations: 254 
?̅?𝑖 = (𝑝1𝑖 + 𝑝2𝑖) 2⁄  255 
𝜃𝑖 = 𝑙𝑜𝑔[(𝑝2𝑖(1 − 𝑝1𝑖)) (𝑝1𝑖(1 − 𝑝2𝑖))⁄ ] 256 
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(3) Simulate cell counts of the 2×2 contingency table from the distributions 𝐵𝑖𝑛(𝑛1𝑖, 𝑝1𝑖) 257 
and 𝐵𝑖𝑛(𝑛2𝑖, 𝑝2𝑖). Apply a continuity correction of 0.5 to studies with zero cell counts. 258 
(4) Calculate 𝜃𝑖 and ?̂?𝑖
2 for log odds ratios from the standard formulae in Borenstein et al. 259 
(1999). 260 
3.2 Parameter values 261 
Parameter values are chosen to represent the range of values observed in published meta-262 
analyses in the Cochrane Database of Systematic Reviews (Langan et al., 2015) and based on 263 
parameter values from previous simulation studies (Langan et al., 2016). For all combinations 264 
of parameter values as outlined in this section, 5000 meta-analyses are simulated. Binary 265 
outcome meta-analyses are simulated with log-odds ratios of 𝜃 = {0,0.5,1.1,2.3} 266 
(corresponding to odds ratios of 1, 1.65, 3, and 10). Standardised mean difference meta-267 
analyses are simulated with 𝜃 = 0.5 only, because previous simulation studies suggest 𝜃 has 268 
no noticeable effect on any of the results (Viechtbauer, 2005; Sanchez-Meca and Marin-269 
Martinez, 2008). Sample sizes are generated from the following five distributions to represent 270 
meta-analyses containing small, small-to-medium, medium, large, and small and large studies: 271 
(1) 𝑁𝑖 = 40, (2) 𝑁𝑖~𝑈(40,400), (3) 𝑁𝑖 = 400, (4) 𝑁𝑖~𝑈(2000,4000), and (5) 𝑁𝑖 = 40 272 
(small) in half of studies and half selected from 𝑁𝑖~𝑈(2000,4000) (large). If k is odd in the 273 
last scenario, one study is selected randomly (with probability 0.5) to be small or large. For 274 
odds ratio meta-analyses, the average event probability (?̅?𝑖) takes the values (1) 0.5, (2) 0.05, 275 
(3) 0.01, and (4) generated from the distribution 𝑈(0.1,0.5). Simulated meta-analyses contain 276 
2, 3, 5, 10, 20, 30, 50, and 100 studies. 277 
Heterogeneity variance parameter values (𝜏2) are defined such that the resulting meta-analyses 278 
span a wide range of levels of inconsistency between study effects. We measured inconsistency 279 
using the 𝐼2 statistic (Higgins and Thompson, 2002), an approximate measure of the relative 280 
size of the heterogeneity variance to the total variability in effect estimates (the sum of within-281 
study error variance and between-study heterogeneity). The chosen 𝜏2 values result in meta-282 
analyses with average 𝐼2 values of 0%, 15%, 30%, 45%, 60%, 75%, 90%, and 95% and are 283 
given in appendix 2. 𝐼2 values are calculated using the true 𝜏2 parameter estimates, but still 284 
vary between simulated meta-analyses because of the simulated variation in the standard errors. 285 
Parameter values for 𝜏2 vary between scenarios with different distributions for 𝑁𝑖 and ?̅?𝑖 to 286 
maintain a consistent range of 𝐼2. In each scenario, 𝜏2 is fixed and 𝐼2 varies between meta-287 
analyses, therefore, we also present the range of 𝐼2 next to the graphs in the results. 288 
Simulating all combinations of parameter values leads to 320 scenarios for standardised mean 289 
difference meta-analyses (8(𝑘) × 5(𝑁𝑖) × 8(𝜏
2)) and 5120 scenarios for odds ratio meta-290 
analyses (8(𝑘) × 5(𝑁𝑖) × 8(𝜏
2) × 4(?̅?𝑖) × 4(𝜃)). Given the large number of simulated 291 
scenarios, this paper can only show results from a representative subset of these scenarios. 292 
3.3 Performance measures 293 
Properties of heterogeneity variance estimators are measured in terms of bias and mean squared 294 
error. These two measures are plotted proportional to the heterogeneity variance parameter 295 
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value, so that results can be compared more easily between scenarios with different 𝜏2. For 296 
example, a proportional bias of 100% means that ?̂?2 is on average twice as large as the true 𝜏2. 297 
By the same token, a proportional bias of −50% means that ?̂?2 is on average half as large as 298 
the true 𝜏2. Similarly, a proportional mean squared error of 100% implies that the mean squared 299 
error is equal to 𝜏2. We also report bias of 𝜃 and coverage of the three included methods to 300 
calculate 95% confidence intervals using estimates from the eleven included heterogeneity 301 
variance estimators. 302 
4 Results 303 
In section 4.1, results are presented for performance measures that relate directly to the 304 
heterogeneity variance parameter; bias and mean squared error. In section 4.2, we present bias 305 
of the summary effect. In section 4.3, we present the coverage probability of the three 306 
confidence interval methods for the summary effect. 307 
4.1 Properties of heterogeneity variance parameter estimates 308 
Estimators are compared in terms of bias in figures 1 and 2 and in terms of mean squared error 309 
in figures 3 and 4. The first figure in each case shows results from standardised mean difference 310 
meta-analyses and the second shows results from odds ratio meta-analyses. We present selected 311 
scenarios containing small studies, small-to-medium studies, and small and large studies 312 
combined with scenarios where the average 𝐼2 is either equal to 30% or 90%, and for 𝜃 = 0.5 313 
only. For odds ratio meta-analyses, we present scenarios where the average event probability 314 
in each study is uniformly distributed between 0.1 and 0.5. In this section, results are 315 
summarised separately for each heterogeneity variance estimator. 316 
DerSimonian-Laird (DL) 317 
In standardised mean difference meta-analyses, DL is negatively biased when 𝐼2 is large and 318 
study sample sizes are small (as shown in figure 1, bottom-left). The estimator is more 319 
negatively biased in the equivalent odds ratio meta-analyses, even with event rates between 0.1 320 
and 0.5 (figure 2). Additionally, DL is negatively biased in odds ratio meta-analyses when 321 
sample sizes are small-to-medium (figure 2, middle-left). In all other scenarios presented in 322 
figures 1 and 2, DL is positively biased in meta-analyses containing fewer than 10-20 studies 323 
and roughly unbiased for those with more studies. DL has similar bias to many estimators 324 
including PMCA, PMDL, and REML in scenarios with small-to-medium studies. In meta-325 
analyses with a mix of small and large studies (figures 1 and 2, third column), DL is one of the 326 
least positively biased estimators - distinctly lower than PM and PMCA. 327 
DL has a relatively low mean squared error in the same scenarios where negative bias is also 328 
observed (figures 3 and 4). However, this is not necessarily a good property because only 329 
underestimates can be truncated to zero and truncation reduces the error of the estimate. Low 330 
mean squared error is also observed in scenarios with small and large studies where DL has 331 
low bias (figures 3 and 4, third column). 332 
11 
 
Cochran’s ANOVA (CA) 333 
CA tends to produce higher estimates of the heterogeneity variance than most other estimators 334 
for both standardised mean difference and odds ratio meta-analyses. As such, CA is roughly 335 
unbiased in scenarios with high 𝐼2 when most other estimators are negatively biased. However, 336 
CA is one of the most positively biased estimators for low to moderate 𝐼2. CA's positive bias 337 
is particularly prominent in scenarios with small and large studies (figures 1 and 2, third 338 
column); it is counterintuitive to assign equal study weights (as the CA estimator does) in these 339 
scenarios with large differences in study size. CA also has higher mean squared error than most 340 
other estimators when the estimator is positively biased (figures 3 and 4). 341 
Paule-Mandel (PM) 342 
PM has properties similar to DL in scenarios of standardised mean difference meta-analyses 343 
that contain small or small-to-medium sized studies (figure 1, first and second column). In 344 
these scenarios, PM is roughly unbiased when 𝐼2 is typically high or the meta-analysis has 345 
more than 20 studies and positively biased otherwise. In scenarios where DL is negatively 346 
biased, PM often has less negative bias, except in scenarios with highly sparse data where all 347 
estimators perform poorly (figure 2, bottom-left). In scenarios with a mix of small and large 348 
studies (figures 1 and 2, third column), PM has a higher mean squared error and higher positive 349 
bias than DL, PMDL, HM, and REML (figures 1-4, third column). 350 
Two-step Cochran’s ANOVA (PMCA) 351 
PMCA uses CA as an initial estimate of heterogeneity. PMCA's bias and mean squared error are 352 
equal to, or somewhere between, CA and PM in all scenarios. Given than CA and PM have 353 
high positive bias and large mean squared error in scenarios with small and large studies, so 354 
too does PMCA (figures 1-4, third column). 355 
Two-step DerSimonian-Laird (PMDL) 356 
In a similar fashion to PMCA, PMDL has bias and mean squared error that is equal to, or 357 
somewhere between, DL and PM in all scenarios. PMDL has properties similar to the best 358 
performing out of the two estimators in all simulated scenarios. In scenarios with large and 359 
small studies, PMDL has low positive bias and mean squared error similar to DL and in 360 
scenarios where DL is negatively biased, PMDL and PM have comparable properties. There is 361 
little difference in the properties of PMDL and REML in all scenarios. 362 
Hartung-Makambi (HM) 363 
In meta-analyses with small or small-to-medium study sizes and zero or low 𝐼2, HM tends to 364 
produce relatively high estimates of heterogeneity and therefore has relatively high positive 365 
bias (figures 1 and 2, top-left). This is perhaps because HM is a transformation of the DL 366 
estimator that only produces positive estimates. HM tends to produce comparatively low 367 
estimates when 𝐼2 is moderate or high and has more negative bias than DL in these scenarios. 368 
HM has a comparatively low mean squared error in all scenarios presented (figures 3 and 4), 369 
including scenarios where HM has high positive bias. HM is one of the best performing 370 
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estimators in meta-analyses containing small and large studies (figures 1-4, third column), with 371 
properties comparable with DL, PMDL, and REML. 372 
Sidik-Jonkman (SJ) 373 
SJ typically produces one of the highest estimates of the heterogeneity variance in both 374 
standardised mean difference and odds ratio meta-analyses; even higher than the other 375 
estimators which only produce positive estimates (HM and SJCA). As such, SJ has considerable 376 
positive bias and high mean squared error in meta-analyses with up to moderate 𝐼2. For 377 
example, in standardised mean difference meta-analyses containing small-to-medium sized 378 
studies and low 𝐼2 (figure 1, top-middle), SJ has bias of more than 100% when almost all other 379 
estimators are roughly unbiased. 380 
Alternative Sidik-Jonkman (SJCA) 381 
SJCA generally has improved properties over the original SJ estimator. In meta-analyses with 382 
small studies (as shown in figures 1 and 2, first column), SJCA is one of the least biased 383 
estimators, with bias similar to many of the truncated methods including DL, PM, and REML. 384 
As the typical study size increases, the extent of SJCA’s positive bias also increases, such that 385 
it becomes one of the most positively biased estimators in meta-analyses with small and large 386 
studies (figures 1 and 2, third column). In scenarios where SJCA has positive bias, it also has 387 
relatively high mean squared error (i.e., in meta-analyses with large studies, see figures 3 and 388 
4, third column). 389 
REML 390 
REML has similar properties to PMDL and DL in most scenarios. In a small number of scenarios 391 
where DL is negatively biased, REML is also negatively biased but often to a much lesser 392 
extent (observed most prominently in figure 2, bottom-left). REML has relatively low bias and 393 
low mean squared error comparable with DL, HM, and PMDL in scenarios containing small 394 
and large studies. 395 
Figure 1: Bias of heterogeneity variance estimates in standardised mean difference outcome 396 
meta-analyses. 397 
Scenarios containing small studies (first row), small-to-medium studies (second row), and 398 
small and large studies (third row). Effect size 𝜃 = 0.5. Note: the y-axis limits differ between 399 
plots.  400 
 401 
Figure 2: Bias of heterogeneity variance estimates in odds ratio meta-analyses with 402 
underlying summary odds ratio 1.65 and an average event probability between 0.1 and 0.5 403 
Scenarios containing small studies (first row), small-to-medium studies (second row), and 404 
small and large studies (third row). Effect size 𝜃 = 0.5. Note: the y-axis limits differ between 405 
plots. 406 
 407 
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Figure 3: Mean squared error of heterogeneity variance estimates in standardised mean 408 
difference outcome meta-analyses. 409 
Scenarios containing small studies (first row), small-to-medium studies (second row), and 410 
small and large studies (third row). Effect size 𝜃 = 0.5. Note: the y-axis limits differ between 411 
plots. 412 
 413 
Figure 4: Mean squared error of heterogeneity variance estimates in odds ratio meta-414 
analyses with underlying summary odds ratio 1.65 and an average event probability between 415 
0.1 and 0.5 416 
Scenarios containing small studies (first row), small-to-medium studies (second row), and 417 
small and large studies (third row). Effect size 𝜃 = 0.5. Note: the y-axis limits differ between 418 
plots. 419 
 420 
4.2 Summary effect estimates 421 
Results show that summary effect estimates (𝜃) are almost unbiased in all scenarios of 422 
standardised mean difference meta-analyses (𝜃 = 0.5) and odds ratio meta-analyses with 423 
common events. However, summary effect estimates are biased towards the null value of zero 424 
in odds ratio meta-analyses with rare events. This is likely to be partly a consequence of the 425 
choice of continuity correction (we added 0.5 to zero cell counts) and the degree of bias was 426 
similar across all heterogeneity variance estimators. We present bias of the summary effect in 427 
the supplementary results only. 428 
4.3 Coverage of 95% summary effect confidence intervals 429 
Coverage is presented in figure 5 for all combinations of heterogeneity variance estimators and 430 
(95%) Wald-type, t-distribution, and HKSJ confidence interval methods for the summary 431 
effect. Results are presented for standardised mean difference meta-analyses only, but results 432 
are consistent with the equivalent scenarios of odds ratio meta-analyses with common events 433 
(event probabilities 0.1 to 0.5, see appendix 3 in the supplementary results). 434 
Wald-type method 435 
Coverage of the 95% Wald-type confidence interval can differ by up to 5% between 436 
heterogeneity variance estimators, up to 30% between numbers of studies, and up to 20% 437 
between heterogeneity values. Coverage varies between 96-100% when studies are 438 
homogeneous and can be as low as 65% when the typical 𝐼2 is 90% (𝜏2 = 0.187) and meta-439 
analyses have two or three studies. When heterogeneity is present, the confidence interval’s 440 
coverage tends towards the nominal value of 95% as the number of studies increases. 441 
Standard t-distribution method 442 
Coverage of the t-distribution 95% confidence interval is generally more robust to changes in 443 
the mean 𝐼2, as shown in figure 5. In these scenarios, however, coverage can differ by up to 444 
5% depending on the heterogeneity variance estimator used and the number of studies. When 445 
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there are 20 studies or more, 95% t-distribution confidence intervals have coverage 94-97%, 446 
but perform conservatively with coverages close to 100% when there are fewer than 20 studies. 447 
The heterogeneity variance estimator that works best with this confidence interval method 448 
varies considerably between scenarios, so it is difficult to select one overall. 449 
Hartung-Knapp-Sidik-Jonkman (HKSJ) method 450 
The HKSJ confidence interval for the summary effect has better coverage than the other two 451 
methods in all scenarios. This method has coverage 94-96% in standardised mean difference 452 
meta-analyses presented in figure 5 and is insensitive to the choice of heterogeneity variance 453 
estimator. The method can produce confidence intervals with sub-optimal coverage in odds 454 
ratio meta-analyses with rare events, where all meta-analysis methods perform poorly (as 455 
demonstrated in the supplementary results, appendix 4). 456 
Figure 5: Coverage of 95% confidence intervals of the summary effect in standardised mean 457 
difference meta-analyses with small-to-medium studies (𝑵𝒊 = 𝑼(𝟒𝟎, 𝟒𝟎𝟎)) 458 
Coverage of Wald-type (first row), t-distribution (second row), and HKSJ (third row) 459 
confidence intervals presented. 460 
4.4 Generalisability of presented results 461 
The results presented so far come from a subset of all simulation scenarios, but these results 462 
can be generalised to some extent. All results are presented in the supplementary material. 463 
First, all results presented in the main paper come from scenarios with standardised mean 464 
difference and log-odds ratio summary effects of 0.5 (odds ratio = 1.65), but results were 465 
consistent with more extreme odds ratio effects in most scenarios. The exception is in odds 466 
ratio meta-analyses containing only small studies with rare events (average event probability = 467 
0.05), where a larger effect size (odds ratio = 10) produced heterogeneity variance estimates 468 
with more negative bias across all methods. Results from other effect sizes are found in the 469 
supplementary results. 470 
Second, results are not presented in the main paper from scenarios where all heterogeneity 471 
variance methods failed with considerable negative bias. This occurred in all scenarios of odds 472 
ratio meta-analyses with rare events (event probability = 0.05 and 0.01) except where study 473 
sizes were large (sample size >4000 per study). In these scenarios, summary effects were 474 
considerably biased and confidence interval methods also failed to produce reasonable 475 
coverage. For example, simulation results show that the HKSJ method can have coverage as 476 
low as 85% in odds ratio meta-analyses with small-to-medium sized studies with an underlying 477 
event probability of 0.05 (see appendix 4). Poor properties were perhaps observed in these 478 
scenarios because many studies contained zero events and a continuity correction was applied 479 
(0.5 was added to all 2x2 cell counts in these simulations). An alternative continuity correction 480 
may have produced different results. 481 
Finally, results were presented thus far are from meta-analyses with typical 𝐼2 values of 0%, 482 
30%, 60%, and 90% (corresponding to four heterogeneity variance parameter values). Meta-483 
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analyses with other typical 𝐼2 values were simulated, but the four presented gave an adequate 484 
description of the properties of methods across all levels of inconsistency. 485 
5 Discussion 486 
The DerSimonian-Laird heterogeneity variance estimator is not recommended for widespread 487 
use in two-stage random-effects meta-analysis and therefore, should not be the default method 488 
for meta-analysis in statistical software packages; it produces estimates with more negative 489 
bias than most other methods in odds ratio meta-analyses with small studies or rare events and 490 
to a lesser extent in standardised mean difference meta-analyses with small studies. This 491 
finding can perhaps be explained by DerSimonian-Laird's fixed-effect study weights that are 492 
based solely on estimated within-study variances; these variances are imprecise and likely to 493 
be biased under such conditions. This observation is in agreement with previous simulation 494 
studies (Sidik and Jonkman, 2007; Panityakul et al., 2013), as identified in a systematic review 495 
(Langan et al., 2016). Viechtbauer (2005) and Böhning et al. (2002) stated that DerSimonian-496 
Laird is unbiased when within-study variances are known. However, DerSimonian-Laird is one 497 
of the better performing estimators in meta-analyses with large differences in study size. 498 
This simulation study identified three heterogeneity variance estimators with more reasonable 499 
properties; REML (Harville, 1977), Paule-Mandel (1982), and the two-step Paule-Mandel that 500 
uses a DerSimonian-Laird initial estimate (DerSimonian and Kacker, 2007). Paule-Mandel is 501 
often approximately unbiased when DerSimonian-Laird is negatively biased. However, results 502 
also show Paule-Mandel has high positive bias when there are large differences in study size. 503 
This can perhaps be attributed to the random-effects study weights used in this method, which 504 
can lead to small studies being given a relatively large weight under heterogeneous conditions. 505 
A similar issue regarding the use of random-effects study weights for summary effect 506 
estimation has been noted elsewhere (Higgins and Spiegelhalter, 2002). The two-step 507 
DerSimonian-Laird estimator (PMDL) inherits most of the best properties of DerSimonian-508 
Laird and Paule-Mandel methods and is simple to compute. REML has very similar properties 509 
to this two-step estimator and is already widely known, recommended in two previous 510 
simulation studies for meta-analyses with continuous (Novianti et al., 2014; Viechtbauer, 2005) 511 
and binary (Viechtbauer, 2005) outcomes. Furthermore, REML is already available in many 512 
statistical software packages (Viechtbauer, 2010; Kontopantelis and Reeves, 2010). Of those 513 
with reasonable properties, REML is the only estimator that assumes normality of effect sizes, 514 
but a previous simulation study (Kontopantelis and Reeves, 2012a; Kontopantelis and Reeves, 515 
2012b) showed all these methods are reasonably robust under non-normal conditions. 516 
One of the aims of this simulation study was to investigate when it is appropriate to rely on one 517 
estimate of the heterogeneity variance. Results show all estimators are imprecise and often fail 518 
to detect high levels of heterogeneity in meta-analyses containing fewer than ten studies. 519 
Furthermore, only 14% of meta-analyses in the Cochrane Database of Systematic Reviews 520 
contain ten studies or more (Langan et al., 2015), so it is rarely appropriate to rely on one 521 
estimate of heterogeneity in this setting. All estimators have poor properties even in meta-522 
16 
 
analyses containing high numbers of studies when study sizes are small or the event of interest 523 
is rare. 524 
Estimates of the summary effect and its HKSJ confidence interval are of less cause for concern, 525 
and perform well even in meta-analyses with only two studies. In particular, the HKSJ 526 
confidence interval offers a large improvement in coverage over the commonly used Wald-527 
type confidence interval. However, caution must still be applied when dealing with meta-528 
analysis datasets with rare events, where summary effects are biased and the HKSJ confidence 529 
interval method can have coverage as low as 85%. Summary effect estimates in this study were 530 
calculated using the inverse-variance approach, though the use of the Mantel-Haenszel method 531 
has been recommended for rare events (Kontopantelis et al., 2013; Bradburn et al., 2007) and 532 
may have improved properties in these scenarios. These findings agree with a previous 533 
simulation study (IntHout et al., 2014), in which the HKSJ method was compared with other 534 
confidence interval methods for both continuous and binary outcome measures. The results 535 
presented in this paper show the HKSJ method is robust to changes in the heterogeneity 536 
variance estimate. 537 
Our findings do not concur with some previous simulation studies. In all cases, this can be 538 
attributed to differences in parameter values and other differences in simulation study design. 539 
The original estimator proposed by Sidik and Jonkman (2005) performed well in the author’s 540 
own simulations, yet simulations in this study shows they have considerable positive bias in 541 
meta-analyses of up to moderate 𝐼2. This was not observed by Sidik and Jonkman (2005) 542 
because simulated meta-analyses were only presented with high 𝐼2 (Langan et al., 2016). The 543 
method of Paule-Mandel has been recommended based on the results of three previous 544 
simulation studies (Novianti et al., 2014; Panityakul et al., 2013; Bhaumik et al., 2012), but 545 
these studies did not simulate meta-analyses with moderate-to-large differences in study size, 546 
where Paule-Mandel has considerable positive bias. Novianti et al. (2014) only recommended 547 
REML for continuous outcome meta-analyses and observed a small negative bias when the 548 
outcome is binary and high 𝐼2; this bias was less pronounced in our simulations with low to 549 
moderate 𝐼2  that Novianti et al (2014) did not include in their simulations (Langan et al., 2016).  550 
The limitations of this simulation study are as follows. First, only a subset of all confidence 551 
interval methods for the summary effect are included. Results show the HKSJ method is more 552 
robust than the Wald method to the choice of heterogeneity variance estimator, but no 553 
confidence interval method can be recommended solely from the results of this study. Other 554 
methods include the profile likelihood method (Hardy and Thompson, 1996), which has also 555 
been shown as a better alternative to the Wald method in simulated meta-analysis data (Henmi 556 
and Copas, 2010) and recommended elsewhere (Cornell, 2014). Second, a continuity correction 557 
of 0.5 was applied whenever simulated studies with a binary outcome contained zero events, 558 
but other methods with a better performance are available (Sweeting et al., 2004). This choice 559 
may have affected the results in scenarios where the event is rare (i.e. 0.05), but alternative 560 
continuity corrections are unlikely to have led to meaningful improvements where the event 561 
rate is extremely rare (i.e. 0.01) and all random-effects methods fail in terms of all performance 562 
measures. We assumed effects to be normally distributed and although this is a limitation, it 563 
has been shown that most of the investigated methods are robust even in extreme non-normal 564 
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distributions (Kontopantelis and Reeves. 2012a). Third, our analyses assume that all studies 565 
provide unbiased estimates of the true effects underlying them. In practice, results of studies 566 
may be biased if the studies are performed sub-optimally, and meta-analyses may be biased if 567 
studies are missing for reasons related to their results (e.g. due to publication bias). These biases 568 
can affect estimation of heterogeneity (both upwardly or downwardly) and lead to 569 
inappropriate conclusions. Finally, although the study aimed to simulate a comprehensive 570 
range of scenarios, this range could never be complete given how diverse meta-analyses are in 571 
practice; not all outcome measures were included (e.g. hazard ratios) and the distributions from 572 
which sample sizes were drawn in this study cannot be considered representative of all 573 
observed distributions because study sample sizes are unlikely to conform to a defined 574 
distribution. 575 
We compared methods in the context of a classical two-stage meta-analysis where study effect 576 
estimates and their standard errors are calculated first, then combined at the second final stage. 577 
Alternatively, one-stage meta-analyses can be undertaken using individual participant data 578 
(IPD) using mixed modelling techniques; these raw data can be derived trivially from study-579 
level 2x2 contingency tables for binary outcome meta-analyses (Stijnen et al., 2010; Simmonds 580 
and Higgins, 2016).  Stijnen et al. (2010) explains that this approach makes random-effects 581 
meta-analyses more feasible with sparse data and does not require a continuity correction in 582 
case of zero events. Jackson et al. (2018) reviewed modelling approaches for this type of meta-583 
analysis data and suggest these models can offer improved statistical inference on the summary 584 
effect. However, these models can present additional numerical issues given their complexity. 585 
Future work comparing the properties of heterogeneity variance methods between one-stage 586 
and two-stage binary outcome meta-analyses would be informative.  587 
The HKSJ method is generally preferred over the Wald-type method. However, Wiksten et al. 588 
(Wilksten et al., 2016) showed it can occasionally lead to less conservative results, even when 589 
the Wald method uses a fixed-effect variance structure. Sidik and Jonkman (2007) proposed a 590 
modification to the HKSJ method to ensure the resulting confidence interval is at least as wide 591 
as the Wald-type fixed-effect confidence interval. We did not apply this modification in our 592 
study. A simulation study by Rover et al. (2015) found the modified method provides coverage 593 
closer to the nominal level when differences in study size were large. 594 
Summarising the properties of a comprehensive list of heterogeneity variance estimators, 595 
compared over many combinations of parameter values was the biggest challenge of this study. 596 
By simulating meta-analyses from a wide range parameter values, inevitably there are scenarios 597 
that reflect meta-analyses rarely observed in practice. For example, most meta-analyses contain 598 
very few studies (Langan et al., 2015; Davey et al., 2011), but meta-analyses with up to 100 599 
studies were simulated in order to show results over the full range of possible meta-analysis 600 
sizes. An attempt was made to focus more on the scenarios representative of real meta-analyses 601 
when interpreting results, but this was inevitably subjective. 602 
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6 Conclusion 603 
A summary of our recommendations are given in table 2. The two-step DerSimonian-Laird 604 
estimator (PMDL) and REML can often be biased, but overall have the most reasonable 605 
properties in standardised mean difference and odds ratio meta-analyses. Of these two 606 
estimators, REML is recommended on the basis of these results because it is already widely 607 
known, available in most statistical software packages, and consistent with the method 608 
commonly used for one-stage meta-analyses using individual participant data (Simmonds et 609 
al., 2015). The two-step DerSimonian-Laird estimator is recommended as an alternative if a 610 
simpler, non-iterative method is required. 611 
The Hartung-Knapp-Sidik-Jonkman confidence interval for the summary effect is generally 612 
recommended over the standard t-distribution and Wald-type methods, particularly in binary 613 
outcome meta-analyses with rare events and the number of studies included is less than 20. To 614 
be consistent, we recommend the same REML estimate of the heterogeneity variance to 615 
calculate this confidence interval. However, this is inconsequential given how robust this 616 
confidence interval is to changes in the heterogeneity variance method in most scenarios. 617 
A REML point estimate, or indeed any other single estimate of heterogeneity, should not be 618 
relied on to gauge the extent of heterogeneity in most meta-analyses. Confidence intervals 619 
should always be reported to express imprecision of the heterogeneity variance estimate. 620 
However, a point estimate can usually be used reliably to calculate a summary effect with a 621 
Hartung-Knapp-Sidik-Jonkman confidence interval. 622 
Table 2: A summary of results and recommendations (considering only REML, PM and 623 
PMDL heterogeneity variance methods, and HKSJ confidence interval)  624 
19 
 
7 References 625 
Bhaumik DK, Amatya A, Normand SLT, et al 2012. Meta-analysis of rare binary adverse 626 
event data. Journal of American Statistical Association; 107(498) 555-567. 627 
Böhning D, Malzahn U, Dietz E, et al 2002. Some general points in estimating heterogeneity 628 
variance with the DerSimonian-Laird estimator. Biostatistics; 3: 445-457. DOI: 629 
10.1093/biostatistics/3.4.445 630 
Borenstein M, Hedges LV and Higgins, JPT 1999. Introduction to Meta-Analysis. Wiley: 631 
Hoboken, NJ, USA. 632 
Bowden J, Tierney J, Copas A, et al 2011. Quantifying, displaying and accounting for 633 
heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC 634 
Medical Research Methodology; 11(1): 41. 635 
Bradburn MJ, Deeks JJ, Berlin JA, et al 2007. Much ado about nothing: a comparison of the 636 
performance of meta‐analytical methods with rare events. Statistics in medicine; 26(1): 53-637 
77. 638 
Chung Y, Rabe-Hesketh S and Choi IH 2013. Avoiding zero between-study variance 639 
estimates in random-effects meta-analysis. Statistics in Medicine; 32(23): 4071-4089. 640 
Cochran WG 1954. The combination of estimates from different experiments. Biometrics; 641 
10(1): 101-129. 642 
Cornell JE 2014. Random-effects meta-analysis of inconsistent effects: a time for change. 643 
Annals of Internal Medicine; 160(4): 267-270. DOI:10.7326/M13-2886 644 
Davey J, Turner RM, Clarke MJ, et al 2011. Characteristics of meta-analyses and their 645 
component studies in the Cochrane Database of Systematic Reviews: a cross-sectional, 646 
descriptive analysis. BMC Medical Research Methodology; 11(1). DOI: 10.1186/1471-2288-647 
11-160 648 
DerSimonian R and Laird, N 1986. Meta-analysis in clinical trials. Controlled Clinical 649 
Trials; 7(3): 177-188. 650 
DerSimonian R, Kacker R 2007. Random-effects model for meta-analysis of clinical trials: 651 
An update. Contemporary Clinical Trials; 28(2): 105-114. DOI: 10.1016/j.cct.2006.04.004 652 
Follmann DA and Proschan MA 1999. Valid inference in random-effects meta-analysis. 653 
Biometrics; 55(3): 732-737. 654 
Hardy RJ and Thompson, SG 1996. A likelihood approach to meta-analysis with random 655 
effects. Statistics in Medicine; 15(6): 619-629. 656 
Hartung, J 1999. An alternative method for meta-analysis. Biometrical Journal; 41, 901–916. 657 
Hartung J and Knapp G 2001. A refined method for the meta-analysis of controlled clinical 658 
trials with binary outcome. Statistics in Medicine 20(24): 3875-3889. 659 
20 
 
Hartung J and Makambi KH 2003. Reducing the number of unjustified significant results in 660 
meta-analysis. Communications in Statistics - Simulation and Computation; 32(4): 1179-661 
1190. DOI: 10.1081/SAC-120023884 662 
Harville DA 1977. Maximum likelihood approaches to variance component estimation and to 663 
related problems. Journal of the American Statistical Association; 72(358): 320-338. DOI: 664 
10.2307/2286796 665 
Henmi M and Copas JB 2010. Confidence intervals for random effects meta-analysis and 666 
robustness to publication bias. Statistics in Medicine; 29(29) 2969-2983. DOI: 667 
10.1002/sim.4029 668 
Higgins JP and Spiegelhalter DJ 2002. Being sceptical about meta-analyses: a Bayesian 669 
perspective on magnesium trials in myocardial infarction. International Journal of 670 
Epidemiology; 31: 96-104. DOI: 10.1093/ije/31.1.96 671 
Higgins JPT and Thompson SG 2002. Quantifying heterogeneity in a meta-analysis. Statistics 672 
in Medicine; 21(11): 1539-1558. DOI: 10.1002/sim.1186 673 
Hunter J and Schmidt F 2004. Methods of Meta-Analysis: Correcting Error and Bias in 674 
Research Findings. SAGE Publications. 675 
IntHout J, Ioannidis JP and Borm GF 2014. The Hartung-Knapp-Sidik-Jonkman method for 676 
random effects meta-analysis is straightforward and considerably outperforms the standard 677 
DerSimonian-Laird method. BMC Medical Research Methodology; 14(1): 25. 678 
Jackson D, Turner R, Rhodes K, et al 2014. Methods for calculating confidence and credible 679 
intervals for the residual between-study variance in random effects meta-regression models. 680 
BMC medical research methodology; 14(1): 103. 681 
Jackson D, Law M, Stijnen T, Viechtbauer W and White IR 2018 (in press). A comparison of 682 
7 random‐effects models for meta‐analyses that estimate the summary odds ratio. Statistics in 683 
Medicine. DOI: 10.1002/sim.7588 684 
Knapp G and Hartung J 2003. Improved tests for a random effects meta-regression with a 685 
single covariate. Statistics in Medicine; 22(17): 2693-2710. 686 
Kontopantelis E and Reeves D 2010. metaan: Random-effects meta-analysis. Stata Journal; 687 
10(3): 395.  688 
Kontopantelis E and Reeves D 2012a. Performance of statistical methods for meta-analysis 689 
when true study effects are non-normally distributed: a simulation study. Statistical methods 690 
in medical research; 21(4): 409-26. 691 
Kontopantelis E, Reeves D 2012b. Performance of statistical methods for meta-analysis when 692 
true study effects are non-normally distributed: A comparison between DerSimonian–Laird 693 
and restricted maximum likelihood. Statistical methods in medical research; 21(6): 657-9. 694 
Kontopantelis E, Springate DA and Reeves D 2013. A re-analysis of the Cochrane library 695 
data: the dangers of unobserved heterogeneity in meta-analyses. PloS One; 8(7): e69930. 696 
21 
 
Langan D, Higgins JPT and Simmonds M 2015. An empirical comparison of heterogeneity 697 
variance estimators in 12,894 meta-analyses. Research Synthesis Methods; 6(2): 195-205. 698 
DOI: 10.1002/jrsm.1140 699 
Langan D, Higgins JPT and Simmonds M 2016. Comparative performance of heterogeneity 700 
variance estimators in meta-analysis: a review of simulation studies. Research Synthesis 701 
Methods; 8(2): 181-198. DOI: 10.1002/jrsm.1198 702 
Malzahn U, Böhning D and Holling H 2000. Nonparametric estimation of heterogeneity 703 
variance for the standardised difference used in meta-analysis. Biometrika; 87(3): 619-632. 704 
DOI: 10.1093/biomet/87.3.619 705 
Morris CN 1983. Parametric empirical Bayes inference: theory and applications. Journal of 706 
the American Statistics Association; 78(381): 47–55. 707 
Novianti PW, Roes KCB and van der Tweel I 2014. Estimation of between-trial variance in 708 
sequential meta-analyses: A simulation study. Contemporary Clinical Trials; 37(1): 129-138. 709 
DOI: 10.1016/j.cct.2013.11.012. 710 
Panityakul T, Bumrungsup C and Knapp G 2013. On Estimating Residual Heterogeneity in 711 
Random-Effects Meta-Regression: A Comparative Study. Journal of Statistical Theory and 712 
Applications; 12(3): 253-265. 713 
Paule RC and Mandel J 1982. Consensus values and weighting factors. Journal of Research 714 
of the National Bureau of Standards; 87(5): 377-385. 715 
Röver C, Knapp G and Friede T 2015. Hartung-Knapp-Sidik-Jonkman approach and its 716 
modification for random-effects meta-analysis with few studies. BMC medical research 717 
methodology; 15(1): 99. 718 
Rukhin AL, Biggerstaff BJ and Vangel MG 2000. Restricted maximum likelihood estimation 719 
of a common mean and the Mandel-Paule algorithm. Journal of Statistical Planning and 720 
Inference; 83(2): 319-330. DOI:10.1016/S0378-3758(99)00098-1 721 
Rukhin, A.L. 2013. Estimating heterogeneity variance in meta‐analysis. Journal of the Royal 722 
Statistical Society: Series B (Statistical Methodology) 75(3) 451-469. 723 
Sanchez-Meca J and Marín-Martínez F 2008. Confidence intervals for the overall effect size 724 
in random-effects meta-analysis. Psychol Methods; 13(1): 31. 725 
Sidik K and Jonkman JN 2002. A simple confidence interval for meta-analysis. Statistics in 726 
Medicine; 21(21): 3153-3159. DOI: 10.1002/sim.1262 727 
Sidik K and Jonkman JN 2005. Simple heterogeneity variance estimation for meta-analysis. 728 
Journal of the Royal Statistical Society: Series C (Applied Statistics); 54(2): 367-384. DOI: 729 
10.1111/j.1467-9876.2005.00489.x 730 
Sidik K and Jonkman JN 2007. A comparison of heterogeneity variance estimators in 731 
combining results of studies. Statistics in Medicine; 26(9): 1964-1981. DOI: 732 
10.1002/sim.2688 733 
Simmonds M, Stewart G and Stewart L 2015. A decade of individual participant data meta-734 
analyses: a review of current practice. Contemporary clinical trials; 45: 76-83. 735 
22 
 
Simmonds M and Higgins JPT 2016. A general framework for the use of logistic regression 736 
models in meta-analysis. Statistical methods in medical research; 25(6): 2858-2877. 737 
Smith TC, Spiegelhalter DJ and Thomas A 1995. Bayesian approaches to random-effects 738 
meta-analysis: A comparative study. Statistics in Medicine; 14(24): 2685-2699 739 
Stijnen T, Hamza TH and Ozdemir P 2010. Random effects meta-analysis of event outcome 740 
in the framework of the generalized linear mixed model with applications in sparse data, 741 
Statistics in Medicine; 29(29): 3046-3067 742 
Sweeting MJ, Sutton AJ and Lambert PC 2004. What to add to nothing? use and avoidance of 743 
continuity corrections in meta-analysis of sparse data. Statistics in Medicine; 23(9): 1351-744 
1375. DOI: 10.1002/sim.1761 745 
Veroniki AA, Jackson D, Viechtbauer W, et al 2015. Methods to estimate heterogeneity 746 
variance and its uncertainty in meta-analysis. Research Synthesis Methods; 7: 55-79. DOI: 747 
10.1002/jrsm.1164 748 
Viechtbauer W 2010. Bias and efficiency of meta-analytic variance estimators in the random-749 
effects model. Journal of Educational and Behavioral Statistics; 30(3): 261-293. DOI: 750 
10.3102/10769986030003261 751 
Viechtbauer W 2010. Conducting meta-analyses in R with the metaphor package. Journal of 752 
Statistical Software; 36(3): 1-48. 753 
Wiksten A, Rücker G, Schwarzer G 2016. Hartung–Knapp method is not always conservative 754 
compared with fixed‐effect meta‐analysis. Statistics in medicine; 35: 2503-2515. DOI: 755 
10.1002/sim.6879  756 
23 
 
Table 1: Nine heterogeneity variance estimators included in this study 757 
 Estimator Acronym 
Method of moments estimators (truncated) 
1 DerSimonian-Laird DL 
2 Cochran’s ANOVA CA 
3 Paule-Mandel PM 
4 Two-step Cochran’s ANOVA PMCA 
5 Two-step DerSimonian-Laird PMDL 
Non-truncated estimators 
6 Hartung-Makambi HM 
7 Sidik-Jonkman SJ 
8 Alternative Sidik-Jonkman SJCA 
Maximum likelihood estimators 
9 Restricted maximum likelihood REML 
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Table 2: A summary of results and recommendations (considering only REML, PM and 759 
PMDL heterogeneity variance methods, and HKSJ confidence interval) 760 
 OR outcome with average event 
probability: 
SMD outcome 0.05 0.1 to 0.5 
Study 
sizes: 
Small 
All estimators have 
substantial negative 
bias in the presence 
of heterogeneity. 
HKSJ confidence 
interval can have 
coverage too 
high/low for >20 
studies (appendix 4). 
REML/PM/PMDL recommended, but all 
estimators biased/imprecise for <10 
studies. HKSJ confidence interval yields 
the nominal coverage. 
Small-to-
medium 
Small 
and large 
REML/PMDL and HKSJ confidence 
interval recommended (as above), but all 
heterogeneity variance estimators 
biased/imprecise for <10 studies. PM 
positively biased. 
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Appendix 1: Proportional bias (left-hand-side) and proportional mean squared error 762 
(right-hand-side) in selected scenarios with estimators proposed by Rukhin (B0, BP) and 763 
Malzahn, Böhning and Holling (MBH) included 764 
Scenarios containing standardised mean difference meta-analyses (𝜃 = 0.5) with 765 
small-to-medium study sizes (𝑁𝑖 = 40 − 400) and an average 𝐼
2 of 60%. 766 
 767 
See separate file for figure.  768 
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Appendix 2: Heterogeneity variance parameter values for each simulated scenario. 769 
 
Study sizes 
Avg. event 
probability 𝐼
2
=
1
5
%
 
𝐼2
=
3
0
%
 
𝐼2
=
4
5
%
 
𝐼2
=
6
0
%
 
𝐼2
=
7
5
%
 
𝐼2
=
9
0
%
 
𝐼2
=
9
5
%
 
odds ratio meta-analyses (𝜃 = 0.5) 
small 
0.5 
0.0670 0.1780 0.3440 0.6330 1.330 4.500 15.60 
small-to-medium 0.0144 0.0333 0.0655 0.1220 0.2440 0.7800 1.670 
medium 0.0067 0.0174 0.0333 0.0560 0.1220 0.3670 0.7800 
small and large 0.0025 0.0066 0.0144 0.0230 0.0756 0.3560 0.7800 
large 0.0001 0.0023 0.0046 0.0082 0.0166 0.0450 0.0100 
small 
0.1 to 0.5 
0.0944 0.2330 0.4450 0.8560 1.89 20.00 * 
small-to-medium 0.0178 0.0433 0.0855 0.1545 0.3220 1.110 2.300 
medium 0.0089 0.0233 0.0433 0.0780 0.1560 0.4500 1.110 
small and large 0.0036 0.0084 0.0178 0.0356 0.0945 0.4560 1.220 
large 0.0012 0.0023 0.0058 0.0107 0.0222 0.0645 0.1340 
small 
0.05 
0.4220 1.156 2.560 7.560 * * * 
small-to-medium 0.0755 0.1890 0.3780 0.7450 1.780 * * 
medium 0.0340 0.0967 0.1890 0.3560 0.7560 3.440 * 
small and large 0.0144 0.0345 0.0745 0.1670 0.4330 2.300 * 
large 0.0053 0.0133 0.0255 0.0445 0.0890 0.2300 0.5600 
small 
0.01 
2.780 14.50 * * * * * 
small-to-medium 0.3780 1.110 2.450 6.700 * * * 
medium 0.1200 0.4500 1.067 2.440 7.800 * * 
small and large 0.0656 0.1780 0.3400 0.1000 3.670 * * 
large 0.0245 0.0622 0.1220 0.2330 0.4780 1.780 * 
standardised mean difference meta-analyses (𝜃 = 0.5) 
small - 0.0178 0.0444 0.0845 0.156 0.322 0.1 2.440 
small-to-medium - 0.00345 0.00856 0.0156 0.023 0.056 0.12 0.3400 
medium - 0.00178 0.00444 0.00844 0.01545 0.0311 0.089 0.1200 
small and large - 0.000656 0.00156 0.00344 0.00744 0.0189 0.089 0.1200 
large - 0.000244 0.00056 0.001133 0.00211 0.00422 0.0133 0.0256 
𝜏2 consistent between numbers of studies and distributions of study effects. 𝐼2 = 0% always 770 
corresponds to 𝜏2 = 0 so these scenarios are not included in the table. 771 
* the given average 𝐼2 could not be attained for any 𝜏2 value, so meta-analyses were not simulated. 772 
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Appendix 3: Coverage of 95% confidence intervals of the summary effect in odds ratio 774 
meta-analyses with small-to-medium studies (𝑵𝒊 = 𝑼(𝟒𝟎, 𝟒𝟎𝟎)) and an average event 775 
probability between 0.1 and 0.5 776 
Coverage of Wald-type (first row), t-distribution (second row), and HKSJ (third row) 777 
confidence intervals presented. 778 
 779 
See separate file for figure.  780 
28 
 
Appendix 4: Coverage of 95% confidence intervals of the summary effect in odds ratio 781 
meta-analyses with small-to-medium studies (𝑵𝒊 = 𝟒𝟎 − 𝟒𝟎𝟎) and an average event 782 
probability of 0.05. 783 
Coverage of Wald-type (first row), t-distribution (second row) and Hartung-Knapp (third 784 
row) confidence intervals presented. 785 
There was no such 𝜏2 that produced a mean 𝐼2 of 90% so scenarios where 𝐼2 = 60% are 786 
presented instead. Effect size 𝜃 = 0.5. 787 
 788 
See separate file for figure. 789 
